Expert Interviews

Existing maternal cardiac risk models showed poor prediction of neonatal complications in pregnancies complicated by congenital heart disease.

Data presented at PAS 2026 show that specific neighborhood factors—not overall scores—drive asthma outcomes, pointing to targeted interventions for reducing ED visits.

Large trial finds balanced fluids and saline yield similar outcomes in pediatric septic shock, reinforcing flexible resuscitation practices.

Natasha Wade, PhD, highlights longitudinal data showing that adolescent cannabis exposure may blunt neurocognitive development over time.

FDA expands teplizumab to children aged ≥1 year with stage 2 T1D, enabling earlier intervention to delay progression to insulin dependence.

New findings highlight elevated secondary cancer risks in adolescent and young adult survivors, underscoring the need for treatment-specific screening strategies.

Marisol Betensky, MD, outlines how dynamic risk evaluation and innovative trial designs can improve anticoagulation decision-making in pediatric VTE care.

Marisol Betensky, MD outlines how institutions can implement risk-stratified guidelines while balancing thrombosis prevention, bleeding risk, and limited evidence.

Mary Pilarz, MD, highlights how allowing families to initiate interpreter use in the PICU boosts utilization and may improve communication equity.

Findings by Conall Watson, PhD, MSc, highlight that maternal RSV vaccination significantly reduces infant hospitalizations—even when given late in pregnancy.

A nationwide analysis of nearly 300,000 infants found that maternal RSV vaccination reduced severe infant hospitalizations by over 80%.

Jennifer Dantzer, MD, discusses how environmental and genetic factors and clinical features shape the diagnosis and management of seasonal allergies in children.

New evidence using sibling-matched analyses suggests no meaningful association between prenatal acetaminophen use and autism.

Henry Xiang, MD, PhD, highlights the importance of thorough follow-up and family resilience in managing mental health outcomes after traumatic brain injury.

Mary Beth Howard, MD, MSc, says rising injury rates among young adolescents reflect a mismatch among rider maturity, high-speed devices, and unsafe riding environments.

Experts say social media–fueled misinformation and evolving policy landscapes are increasing vaccine hesitancy.

Katharine P. Callahan, MD, MSME, highlights how rapid genomic testing in neonatal intensive care offers critical diagnostic and prognostic insight.

Tami Katzir, PhD, and Rotem Yinon, PhD, discuss emerging evidence that brief kindergarten screening tools can identify dyslexia risk across development.

Trofinetide offers the first targeted treatment for Rett syndrome, with a new, convenient powdered formulation aimed at significantly reducing adverse effects.

Lara McKenzie, PhD, emphasizes the urgent need for strong child-resistant packaging to prevent accidental exposures.

Data found that mavacamten significantly reduces cardiac obstruction and improves clinical markers in adolescents with symptomatic obstructive hypertrophic cardiomyopathy.

The FDA has updated its approval for 1-mg epinephrine nasal spray, removing the age limit to allow all patients weighing at least 33 lb to access the treatment.

Rachel Rosales, MPH, explores how mandatory reporting and integrated care models can address the structural barriers preventing consistent behavioral health screenings.

As we step into Q2 2026, take a look back at our top video interviews and packages of Q1.

Perry Rosen, MD, offers essential guidance for clinicians on prevention and emergency management of pediatric nicotine poisoning.

A 7460% increase in pediatric inhalation exposures since 2016 highlights the need for child-resistant designs and updated parental guidance.

Linda Stein Gold, MD, discusses the promising safety and efficacy of tapinarof cream, 1%, as a nonsteroidal treatment for pediatric patients with atopic dermatitis.

Jennifer Hoffmann, MD, MS, discusses the high rates of overtriage in children with behavioral health symptoms and the need for more objective triage tools.

Margeaux Naughton, MD, discusses the Pediatric Psychiatry Colocalized Consult Clinic model, a strategic approach to improve mental health access and provider training.

Ashley Shoemaker, MD, MSci, discusses the evolving clinical pathways for managing rare genetic and acquired hypothalamic obesity in pediatric patients.